Table 2

Study characteristics

Diagnostic criteriaDuration of complaints (weeks)Orthotic group (O)Control group (C)Follow-up time (weeks)Outcome measureChange scores*Mean difference (95% CI)Effect size
TreatmentNo of subjectsTreatmentNo of subjects
RCTs of knee braces and exercise therapy vs exercise therapy only
 Denton et al15
  PFPS
34% female
Age: 13–55 years
Mean (SD): 28 (?)
>4Protonics system and exercise therapy17Exercise therapy176Pain: VPS during:
Lateral step-up testO: 4.61.3
C: 3.3
Function: KPSO: 28.94.9
C: 24
Performance: Step-up testO: 4−1
C: 5
 Miller et al19
  AKP
19% female
Age: ?
3Palumbo dynamic patellar brace and exercise therapy20Exercise therapy132–3Pain: VAS during:
ActivityO: 2.041.35
C: 0.69
Cho Pad knee strap and exercise therapy18Exercise therapy132–3Pain: VAS during activityO: 1.781.09
C: 0.69
 Lun et al18
  PFPS
79% female
Age: 18–60 years
Mean (SD): 35 (?)
2Home exercise therapy and a Y-shaped patellar brace32Home exercise therapy3412Pain: VAS during:
Sport activityO: 1.50 (−0.61 to 0.61)0
C: 1.5
1 h after sport activityO: 1.5−0.4 (−0.95 to 0.15)−0.14
C: 1.9
Following 30 min of sitting with flexed kneesO: 1.50.1 (−0.53 to 0.83)0.04
C: 1.4
Function: KFO: 2−3 (−5.06 to −0.95)§−0.33
C: 5
RCT of knee braces and exercise therapy vs placebo braces and exercise therapy
Lun et al18
 PFPS
79% female
Age: 18–60 years
Mean (SD): 35 (?)
2Home exercise therapy and a Y-shaped patellar brace32Home exercise therapy and knee sleeve3112Pain: VAS during:
Sport activityO: 1.60.1 (−0.57 to 0.77)0.03
C: 1.5
1 h after sport activityO: 2.20.3 (−0.28 to 0.88)0.10
C: 1.9
Following 30 min of sitting with flexed kneesO: 1.60.2 (−0.47 to 0.87)0.06
C: 1.4
Function: KFO: 4−1 (−2.98 to 0.98)−0.12
C: 5
RCT of tape and exercise therapy vs exercise therapy only
Whittingham et al20
  PFPS
20% female
Age: 17–25 years
Mean (SD) 18.7 (1.2)
?Medially directed tape and exercise therapy10Exercise therapy104Pain: VAS during:
Pervious 24 hO: 7.5C: 5.71.8 (1.60 to 2.00)§2.00
A step test without tapeO: 7.41.7 (1.50 to 1.99)§1.89
C: 5.7
Function: FIQO: 8.42.6 (2.38 to 2.82)§2.89
C: 5.8
 Clark et al13
  AKP/PFPS
44% female
Age: 15–40 years
Mean (SD) ?
>12Education, exercise therapy and tape20Education and exercise therapy2012Pain: Mean VAS during:
Climbing stairs and walkingO: 39.7−7.4 (−18.03 to 3.23)−0.19
C: 47.1
Function: WOMACO: 13.70 (−3.45 to 3.45)0
C: 13.7
52Pain: Mean VAS during climbing stairs and walkingO: 40.00.7 (−6.30 to 7.70)0.02
C: 39.3
Function: WOMACO: 10.4C: 8.12.3 (−3.00 to 7.60)0.18
 Kowall et al17
  ?68% female
Age: 14–40 years
Mean (SD) 29 (?)
>4Exercise therapy and tape12Exercise therapy134Pain: VASO: 1400
C: 14
RCT of tape and exercise therapy vs placebo tape and exercise therapy
 Whittingham et al20
  PFPS
20% female
Age: 17–25 years
Mean (SD) 18.7 (1.2)
?Medially directed tape and exercise therapy10Placebo tape and exercise therapy104Pain: VAS during:
Pervious 24 hO: 7.50.9 (0.75 to 1.05)§1.00
C: 6.6
A step test without tapeO: 7.41.1 (0.99 to 1.21)§1.38
C: 6.3
Function: FIQO: 8.42.7 (2.46 to 2.94)§3
C: 5.7
RCT of foot orthotics and exercise therapy vs exercise therapy only
 Collins et al14
  PFPS
55.9% female
Age: 18–40 years
Mean (SD) 29.3 (5.8)
>6Exercise therapy and foot orthotics44Exercise therapy456Pain: VAS for:
Usual painO: 19.4−1.8 (−5.40 to 1.80)−0.10
C: 21.2
Worst painO: 28.5−3.6 (−5.90 to 1.29)−0.22
C: 32.2
Function: KPSO: 83.60.2 (−1.69 to 2.09)0.02
C: 83.4
Function: FIQO: 13.30.5 (0.26 to 0.74)§0.22
C: 12.9
52Pain: VAS for:
Usual painO: 14.40.4 (−3.45 to 4.25)0.02
C: 13.9
Worst painO: 18.8−3.3 (−8.24 to 1.64)0.20
C: 22.2
Function: KPSO: 91.53.6 (1.58 to 5.61)§0.34
C: 87.9
Function: FIQO: 13.8−0.5 (−1.04 to 0.04)−0.22
C: 14.2
 Eng and Pierrynowski16
  PFPS
100% female
Age: 13–17 years
Mean (SD) 14.8 (1.2)
>6Exercise therapy and foot orthotics10Exercise therapy106Pain: VAS during:
WalkingO: 21.5
C: 0.5
RunningO: 32.5§
C: 0.5
  • ? indicates unknown/not reported.

  • * Change scores in the O and C group. Positive scores indicate improvement, ie, less pain or better function.

  • Difference in change scores between O and C.

  • Not enough information was provided to make this assessment.

  • § Significant difference between orthotics group and control group.

  • Data abstracted from figures.

  • AKP, anterior knee pain; FIQ, functional index questionnaire (0–16); KF, knee function scale (0–53); KPS, Kujala patellofemoral score (0–100); PFPS, patellofemoral pain syndrome; RCT, randomised controlled trial; VAS, visual analogue scale score (0–100); VPS, verbal pain score (0–10); WOMAC, Western Ontario and McMaster Universities Osteoarthritis Questionnaire (0–100).